I E Smith

4.6k citations

59 papers · 3.5k indexed · 1 hit paper · h-index 23

Impact in

Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis

Papers in ⓘ

Cancer Research 14
- Breast Cancer Treatment Studies 12
Oncology 25
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 7
- Lung Cancer Research Studies 7

Co-authors: Mitch Dowsett (19 shared papers)R. Charles Coombes (3 shared papers)N. Lynn Henry (1 shared paper)Christos Sotiriou (1 shared paper)Torsten O. Nielsen (2 shared papers)Janine Salter (1 shared paper)J. Zujewski (1 shared paper)Roger A’Hern (1 shared paper)
Journals: British Journal of Cancer (11 papers)European Journal of Cancer (6 papers)The Breast (3 papers)Annals of Oncology (3 papers)Thorax (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

I E Smith

58 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group 2011 · 1.5k citations

Peers

Countries citing papers authored by I E Smith

Since Specialization

Citations

This map shows the geographic impact of I E Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I E Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I E Smith more than expected).

Fields of papers citing papers by I E Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I E Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I E Smith. The network helps show where I E Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside I E Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I E Smith Line = papers co-authored together I E Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group JNCI Journal of the National Cancer Institute ·M. Dowsett, Torsten O. Nielsen, Roger A’Hern, (unknown), R. Charles Coombes, J Cuzick, Mathew J. Ellis, N. Lynn Henry, Judith Hugh, Tracy Lively, Lisa M. McShane, Seungmok Paik, Frédérique Penault–Llorca, Ludmila Prudkin, MM Regan, Janine Salter, Christos Sotiriou, I E Smith, G. Viale, J. Zujewski, Daniel F. Hayes Hit paper breakdown →	2011	1488
2	Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. Journal of Clinical Oncology ·P Dombernowsky, I E Smith, Geoffrey Falkson, Robert Leonard, Lawrence Panasci, J Bellmunt, W. R. Bezwoda, G. Gardin, A. Gudgeon, Myfanwy Morgan, A. Fornasiero, W. Hoffmann, Jan Michel, Thomas Hatschek, T Tjabbes, H.A. Chaudri, Ulrike Hornberger, P Trunet	1998	473
3	Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer. PubMed ·Jacqueline C. Newby, Stephen Johnston, I E Smith, Mitch Dowsett	1997	156
4	Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized31P measurements of response to treatment NMR in Biomedicine ·Martin O. Leach, Mark Verrill, J. Glaholm, Timothy Smith, Dave Collins, Geoffrey S. Payne, Jonathan C. Sharp, Sabrina M. Ronen, V. R. McCready, T.J. Powles, I E Smith	1998	115
5	Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer. PubMed ·Timothy Iveson, I E Smith, Julie Ahern, D A Smithers, P Trunet, Mitch Dowsett	1993	110
6	Activity of docetaxel (Taxotere) in small cell lung cancer European Journal of Cancer ·J F Smyth, I E Smith, C. Sessa, Patrick Schöffski, J. Wanders, H. Franklin, Stuart Kaye	1994	105
7	Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells Lung Cancer ·Valentine M. Macaulay, MJ Everard, J D Teale, P. A. Trott, Judson J. Van Wyk, I E Smith, Jeremy Millar	1991	85
8	Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer British Journal of Cancer ·Adrian L. Harris, Mitch Dowsett, I E Smith, S.L. Jeffcoate	1983	72
9	Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. PubMed ·Mitch Dowsett, C. Pfister, S R Johnston, D.W. Miles, Stephen Houston, J. Arnold Verbeek, Holly Gundacker, A. Sioufi, I E Smith	1999	70
10	Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma. PubMed ·I E Smith, Adrian L. Harris, Myfanwy Morgan, J C Gazet, J A McKinna	1982	68
11	Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer British Journal of Cancer ·VM Macauly, J D Teale, MJ Everard, GP Joshi, I E Smith, JL Millar	1988	55
12	LOW-DOSE AMINOGLUTETHIMIDE IN TREATMENT OF ADVANCED BREAST CANCER The Lancet ·R. Stuart‐Harris, Thomas Bozek, J C Gazet, A Kurkure, Mitch Dowsett, J A McKinna, S.L. Jeffcoate, Laurie Carr, I E Smith	1984	51
13	‘Tomudex’ (ZD1694) : A novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours Annals of Oncology ·David Cunningham, John Zalcberg, I E Smith, M. Gore, Richard Pazdur, Howard A. Burris, N J Meropol, Gerard T. Kennealey, Leonard W. Seymour	1996	45
14	A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients British Journal of Cancer ·Mitch Dowsett, Adrian L. Harris, R. Stuart‐Harris, Martin Hill, B.M.J. Cantwell, I E Smith, S.L. Jeffcoate	1985	45
15	ENDOCRINE EFFECTS OF LOW DOSE AMINOGLUTETHIMIDE AS AN AROMATASE INHIBITOR IN THE TREATMENT OF BREAST CANCER Clinical Endocrinology ·R. Stuart‐Harris, Mitch Dowsett, Alaric W. D’Souza, A. Donaldson, Adrian L. Harris, S.L. Jeffcoate, I E Smith	1985	39
16	Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer European Journal of Cancer ·Mitch Dowsett, D A Smithers, John W. Moore, P Trunet, R. Charles Coombes, TJ Powles, R.D. Rubens, I E Smith	1994	36
17	High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer European Journal of Cancer and Clinical Oncology ·Christopher J. Gallagher, F. Cairnduff, I E Smith	1987	32
18	The effect of a low-fat diet on hormone levels in healthy pre- and postmenopausal women: relevance for breast cancer European Journal of Cancer ·I.L. Crighton, Mitch Dowsett, Maureen Hunter, Clare Shaw, I E Smith	1992	28
19	Role of aminoglutethimide in male breast cancer British Journal of Cancer ·Adrian L. Harris, Mitch Dowsett, R. Stuart‐Harris, I E Smith	1987	27
20	Long term non-invasive domiciliary assisted ventilation for respiratory failure following thoracoplasty. Thorax ·Matthew J. Jackson, I E Smith, M. T. King, John M. Shneerson	1994	24

About I E Smith

I E Smith is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pharmacology, having authored 59 papers that have together received 3.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (18 papers), Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (9 papers), HER2/EGFR in Cancer Research (7 papers), Lung Cancer Research Studies (7 papers), Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Respiratory Support and Mechanisms (4 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.8k citations), Genetics (1.1k citations), Pathology and Forensic Medicine (457 citations) and Pulmonary and Respiratory Medicine (657 citations). I E Smith has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mitch Dowsett, R. Charles Coombes, N. Lynn Henry, Christos Sotiriou, Torsten O. Nielsen, Janine Salter, J. Zujewski, Roger A’Hern, Ludmila Prudkin and Mathew J. Ellis. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, The Breast, Annals of Oncology and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact